ArticleProstate cancer and prostatic diseases2022

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.

Daniel J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.